Uneventful octreotide LAR therapy throughout three pregnancies, with favorable delivery and anthropometric measures for each newborn: a case report

Table 1 Patient's endocrine-biochemical laboratory tests^a

	Time phase
Test	Baseline	1 month post-surgery	Recurrence 15 months	Steroid blocker treatment 20 months	Octreotide LAR treatment 102 months
Plasma cortisol, nmol/L*	1700	1193	> 1379	495	219
Urinary free cortisol**	1994	2952	5171	1107	120
Plasma ACTH	21.1†		23.2†	17.3†	10.2††
Urinary 5-HIAA‡	6		8.4		3.7

^aACTH, adrenocorticotropic hormone; 5-HIAA, 5-hydroxyindoleacetic acid; *normal range 138 to 690 nmol/24 hours; **normal range 55 to 248 nmol/24 hours; †normal range 4.4 to 17.6 pmol/L; ††normal range 0 to 10 pmol/L; ‡normal range 1 to 84 mg/g creatinine.

ISSN: 1752-1947